Healthcare Trust of America, Inc. Reports Second Quarter 2019 Earnings

HTA ended Q2 2019 with net income attributable to common stockholders of $0.08 per diluted share, Normalized FFO of $0.41 per diluted share, Same-Property Cash NOI growth of 2.9% and has completed $111 million of investments to date.

 

SCOTTSDALE, Ariz., July 23, 2019 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE: HTA) ("HTA") announced results for the three and six months ended June 30, 2019.

Healthcare Trust of America, Inc. Logo.

HTA ended Q2 2019 with net income attributable to common stockholders of $0.08 per diluted share, Normalized FFO of $0.41 per diluted share, Same-Property Cash NOI growth of 2.9% and has completed $111 million of investments to date.

Highlights

Second Quarter 2019:

  • Net Income Attributable to Common Stockholders was $16.3 million, or $0.08 per diluted share, an increase of $0.01 per diluted share, compared to Q2 2018.
  • Funds From Operations ("FFO"), as defined by the National Association of Real Estate Investment Trusts ("NAREIT"), was $84.6 million, or $0.40 per diluted share, for Q2 2019. Due to the adoption of Topic 842, initial direct costs are now reported in general and administrative expenses. For Q2 2018, HTA capitalized approximately $0.9 million of initial direct costs.
  • Normalized FFO was $85.2 million, or $0.41 per diluted share, for Q2 2019.
  • Normalized Funds Available for Distribution ("FAD") was $73.1 million for Q2 2019.
  • Same-Property Cash Net Operating Income ("NOI") increased $3.2 million, or 2.9%, to $112.5 million, compared to Q2 2018.
  • Leasing: HTA's portfolio had a leased rate of 91.6% by gross leasable area ("GLA") and an occupancy rate of 90.6% by GLA for Q2 2019. During Q2 2019, HTA executed approximately 0.8 million square feet of GLA of new and renewal leases. Re-leasing spreads increased to 3.6% and tenant retention for the Same-Property portfolio was 83% by GLA for Q2 2019.

Year-to-Date 2019:

  • Net Income Attributable to Common Stockholders was $29.7 million, or $0.14 per diluted share, an increase of $0.02 per diluted share, compared to 2018.
  • FFO, as defined by NAREIT, was $167.4 million, or $0.80 per diluted share, for 2019. For 2018, HTA capitalized approximately $2.2 million of initial direct costs.
  • Normalized FFO was $168.3 million, or $0.81 per diluted share, for 2019.
  • Normalized FAD was $146.3 million for 2019.
  • Same-Property Cash NOI increased $6.3 million, or 2.9%, to $223.8 million, compared to 2018.
  • Leasing: During the six months ended June 30, 2019, HTA executed approximately 1.9 million square feet of GLA of new and renewal leases, or over 8.1%, of the total GLA of its portfolio. Re-leasing spreads increased to 4.7% and tenant retention for the Same-Property portfolio was 85% by GLA year-to-date.

Balance Sheet and Capital Markets

  • Balance Sheet: HTA ended Q2 2019 with total liquidity of $1.0 billion, inclusive of $23.2 million of cash and cash equivalents, and a $52.1 million forward equity agreement, resulting in total leverage of (i) 30.7%, measured as debt less cash and cash equivalents to total capitalization, and (ii) 5.7x, measured as debt less cash and cash equivalents to Adjusted Earnings before Interest, Taxes, Depreciation and Amortization for real estate ("Adjusted EBITDAre").
  • Equity: In June 2019, under its at-the-market ("ATM") offering program, HTA entered into a forward sale arrangement in which it would issue approximately 1.8 million shares of common stock to receive anticipated net proceeds of approximately $52.1 million prior to June 2020, subject to adjustments as provided in the forward equity agreement.

Noteworthy 2019 Activities

  • Investments: To date, HTA has closed on approximately $111 million of investments totaling approximately 320,000 square feet of GLA with $74.1 million closed during Q2 2019 and $18.0 million closed subsequent to Q2 2019. These investments are primarily located in HTA's existing key markets and acquired at average capitalization rates of 5.5%. The key acquisitions are highlighted by the following:
    • Streeterville Center: An on-campus MOB located adjacent to Northwestern Memorial Hospital, in downtown Chicago, IL. We acquired the 72,000 square foot MOB for $40.0 million. It is approximately 98% leased and will be operated by HTA's internal asset management platform.
    • Charlotte MOBs: Two MOBs located in affluent Charlotte, NC suburbs for $20.3 million totaling 73,000 square feet of GLA. These include an MOB adjacent to Novant Huntersville hospital campus and a core community MOB in close proximity to Davidson College. With these acquisitions, HTA's Charlotte, NC presence will increase to over 400,000 square feet of GLA, allowing HTA to bring its assets onto its internal asset management platform allowing HTA to expand its key health system relationships.
    • Fairfax MOB: An MOB investment of $18.0 million closed subsequent to Q2 2019, totaling approximately 57,000 square feet of GLA and approximately 98% leased.
  • Dividends: On July 23, 2019, HTA's Board of Directors announced an increased quarterly cash dividend of $0.315 per share of common stock and per OP Unit. The quarterly dividend is to be paid on October 10, 2019 to stockholders of record of its common stock and holders of its OP Units on October 3, 2019.

Impact of Topic 842 Leases

  • The Financial Accounting Standards Board issued Topic 842, which was effective for HTA as of January 1, 2019. Topic 842 modifies the treatment of initial direct costs, which historically under Topic 840 were capitalized in accordance with certain criteria provided for in the applicable guidance. Topic 842 also eliminates the accounting recognition of expenses paid directly by tenants and moves certain bad debt costs from expense to revenue. During the three and six months ended Q2 2018, HTA capitalized $0.9 million and $2.2 million, respectively, of initial direct costs that would now be expensed under Topic 842. In addition, for the three and six months ended Q2 2018, HTA recognized $3.4 million and $7.0 million, respectively, of tenant paid property taxes in both revenues and expenses and a nominal amount of bad debt costs recognized as expenses.

2019 Guidance

For 2019, HTA updated its earnings guidance as follows:

   

Annual Expectations

   

Low

to

High

Net income attributable to common stockholders per share

 

$0.33

 

$0.36

         

Same-Property Cash NOI

 

2.0%

 

3.0%

         

FFO per share, as defined by NAREIT

 

$1.62

 

$1.64

         

Normalized FFO per share

 

$1.63

 

$1.65

About Healthcare Trust of America, Inc.

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 23.3 million square feet of GLA, with $6.9 billion invested primarily in MOBs.  HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations.  Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth.  The strategic markets HTA invests in support a strong, long-term demand for quality medical office space.  HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market.  This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation.  Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level.

Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the S&P 500 and US REIT index.  More information about HTA can be found on the Company's Website (www.htareit.com), Facebook, LinkedIn and Twitter.

Forward-Looking Language

This press release contains certain forward-looking statements with respect to HTA.  Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management's intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements.  These risks, uncertainties and contingencies include, without limitation, the following: changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in our proposed market areas; changes in accounting principles generally accepted in the United States of America; policies and guidelines applicable to REITs; the availability of properties to acquire; and the availability of financing.  Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our 2018 Annual Report on Form 10-K and in our filings with the SEC.

Conference Call

HTA will host a conference call and webcast on Wednesday, July 24, 2019 at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time) to review its financial performance and operating results for the three and six months ended June 30, 2019.

Conference Call and Webcast Details:
Domestic Dial-In Number: (877) 507-6265
International Dial-In Number: (412) 902-6633
Canada Dial-In Number: (855) 669-9657
Webcast: www.htareit.com under the Investor Relations tab

Replay Conference Call Details:
Domestic Dial-In Number: (877) 344-7529
International Dial-In Number: (412) 317-0088
Canada Dial-In Number: (855) 669-9658
Conference ID: 10133084
Available July 24, 2019 (one hour after the end of the conference call) to August 24, 2019 at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time)

Financial Contact:
Robert A. Milligan
Chief Financial Officer
480.998.3478

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except for share and per share data)

(Unaudited)

 
 

June 30, 2019

 

December 31, 2018

ASSETS

     

Real estate investments:

     

Land

$

492,770

   

$

481,871

 

Building and improvements

5,886,129

   

5,787,152

 

Lease intangibles

598,022

   

599,864

 

Construction in progress

8,907

   

4,903

 
 

6,985,828

   

6,873,790

 

Accumulated depreciation and amortization

(1,324,281)

   

(1,208,169)

 

Real estate investments, net

5,661,547

   

5,665,621

 

Investment in unconsolidated joint venture

66,731

   

67,172

 

Cash and cash equivalents

23,194

   

126,221

 

Restricted cash

5,950

   

7,309

 

Receivables and other assets, net

225,681

   

223,415

 

Right-of-use assets, net

245,495

   

 

Other intangibles, net

11,877

   

98,738

 

Total assets

$

6,240,475

   

$

6,188,476

 

LIABILITIES AND EQUITY

     

Liabilities:

     

Debt

$

2,567,008

   

$

2,541,232

 

Accounts payable and accrued liabilities

159,853

   

185,073

 

Security deposits, prepaid rent and other liabilities

41,241

   

59,567

 

Lease liabilities

200,842

   

 

Intangible liabilities, net

40,529

   

61,146

 

Total liabilities

3,009,473

   

2,847,018

 

Commitments and contingencies

     

Redeemable noncontrolling interests

   

6,544

 

Equity:

     

Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding

   

 

Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 205,117,620 and 205,267,349 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively

2,051

   

2,053

 

Additional paid-in capital

4,521,103

   

4,525,969

 

Accumulated other comprehensive (loss) income

(449)

   

307

 

Cumulative dividends in excess of earnings

(1,369,763)

   

(1,272,305)

 

Total stockholders' equity

3,152,942

   

3,256,024

 

Noncontrolling interests

78,060

   

78,890

 

Total equity

3,231,002

   

3,334,914

 

Total liabilities and equity

$

6,240,475

   

$

6,188,476

 

 

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 
 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

2019

 

2018

 

2019

 

2018

Revenues:

             

Rental income

$

171,609

   

$

173,221

   

$

340,484

   

$

348,788

 

Interest and other operating income

148

   

111

   

239

   

205

 

Total revenues

171,757

   

173,332

   

340,723

   

348,993

 

Expenses:

             

Rental

52,938

   

53,553

   

104,406

   

109,575

 

General and administrative

10,079

   

8,725

   

21,369

   

17,511

 

Transaction

296

   

396

   

336

   

587

 

Depreciation and amortization

68,429

   

69,104

   

137,910

   

139,496

 

Interest expense

24,006

   

26,305

   

47,976

   

52,558

 

Impairment

   

   

   

4,606

 

Total expenses

155,748

   

158,083

   

311,997

   

324,333

 

Loss on sale of real estate, net

   

   

(37)

   

 

Income from unconsolidated joint venture

548

   

403

   

1,034

   

973

 

Other income

41

   

5

   

576

   

40

 

Net income

$

16,598

   

$

15,657

   

$

30,299

   

$

25,673

 

Net income attributable to noncontrolling interests

(339)

   

(311)

   

(600)

   

(525)

 

Net income attributable to common stockholders

$

16,259

   

$

15,346

   

$

29,699

   

$

25,148

 

Earnings per common share - basic:

             

Net income attributable to common stockholders

$

0.08

   

$

0.07

   

$

0.14

   

$

0.12

 

Earnings per common share - diluted:

             

Net income attributable to common stockholders

$

0.08

   

$

0.07

   

$

0.14

   

$

0.12

 

Weighted average common shares outstanding:

             

Basic

205,108

   

205,241

   

205,094

   

205,155

 

Diluted

209,005

   

209,259

   

209,002

   

209,218

 

Dividends declared per common share

$

0.310

   

$

0.305

   

$

0.620

   

$

0.610

 

 

HEALTHCARE TRUST OF AMERICA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 
 

Six Months Ended June 30,

 

2019

 

2018

Cash flows from operating activities:

     

Net income

$

30,299

   

$

25,673

 

Adjustments to reconcile net income to net cash provided by operating activities:

     

Depreciation and amortization

132,931

   

135,177

 

Share-based compensation expense

5,491

   

5,703

 

Impairment

   

4,606

 

Income from unconsolidated joint venture

(1,034)

   

(973)

 

Distributions from unconsolidated joint venture

1,335

   

975

 

Loss on sale of real estate, net

37

   

 

Changes in operating assets and liabilities:

     

Receivables and other assets, net

457

   

(2,956)

 

Accounts payable and accrued liabilities

(23,262)

   

(13,254)

 

Prepaid rent and other liabilities

2,483

   

1,157

 

Net cash provided by operating activities

148,737

   

156,108

 

Cash flows from investing activities:

     

Investments in real estate

(93,855)

   

(11,887)

 

Development of real estate

(4,627)

   

(23,861)

 

Proceeds from the sale of real estate

1,193

   

 

Capital expenditures

(37,763)

   

(34,110)

 

Collection of real estate notes receivable

365

   

347

 

Net cash used in investing activities

(134,687)

   

(69,511)

 

Cash flows from financing activities:

     

Borrowings on unsecured revolving credit facility

135,000

   

85,000

 

Payments on unsecured revolving credit facility

(15,000)

   

(85,000)

 

Payments on secured mortgage loans

(96,173)

   

(99,218)

 

Security deposits

   

222

 

Proceeds from issuance of common stock

   

72,814

 

Repurchase and cancellation of common stock

(12,095)

   

(11,553)

 

Dividends paid

(127,387)

   

(125,128)

 

Distributions paid to noncontrolling interest of limited partners

(2,781)

   

(2,689)

 

Net cash used in financing activities

(118,436)

   

(165,552)

 

Net change in cash, cash equivalents and restricted cash

(104,386)

   

(78,955)

 

Cash, cash equivalents and restricted cash - beginning of period

133,530

   

118,560

 

Cash, cash equivalents and restricted cash - end of period

$

29,144

   

$

39,605

 

 

HEALTHCARE TRUST OF AMERICA, INC.

NOI, CASH NOI AND SAME-PROPERTY CASH NOI

(In thousands)

(Unaudited)

 
 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

2019

 

2018

 

2019

 

2018

Net income

$

16,598

   

$

15,657

   

$

30,299

   

$

25,673

 

General and administrative expenses

10,079

   

8,725

   

21,369

   

17,511

 

Transaction expenses

296

   

396

   

336

   

587

 

Depreciation and amortization expense

68,429

   

69,104

   

137,910

   

139,496

 

Impairment

   

   

   

4,606

 

Interest expense

24,006

   

26,305

   

47,976

   

52,558

 

Loss on sale of real estate, net

   

   

37

   

 

Income from unconsolidated joint venture

(548)

   

(403)

   

(1,034)

   

(973)

 

Other income

(41)

   

(5)

   

(576)

   

(40)

 

NOI

$

118,819

   

$

119,779

   

$

236,317

   

$

239,418

 

NOI percentage growth

(0.8)

%

     

(1.3)

%

   
               

NOI

$

118,819

   

$

119,779

   

$

236,317

   

$

239,418

 

Straight-line rent adjustments, net

(2,464)

   

(2,377)

   

(5,722)

   

(5,543)

 

Amortization of (below) and above market leases/leasehold interests, net and other GAAP adjustments

(357)

   

55

   

(123)

   

176

 

Notes receivable interest income

(25)

   

(34)

   

(52)

   

(70)

 

Cash NOI

$

115,973

   

$

117,423

   

$

230,420

   

$

233,981

 

Acquisitions not owned/operated for all periods presented and disposed properties Cash NOI

(1,457)

   

(5,002)

   

(2,413)

   

(10,216)

 

Redevelopment Cash NOI

(845)

   

(1,784)

   

(1,951)

   

(3,505)

 

Intended for sale Cash NOI

(1,194)

   

(1,317)

   

(2,250)

   

(2,706)

 

Same-Property Cash NOI (1)

$

112,477

   

$

109,320

   

$

223,806

   

$

217,554

 

Same-Property Cash NOI percentage growth

2.9

%

     

2.9

%

   
 

(1) Same-Property includes 408 and 407 buildings for the three and six months ended June 30, 2019 and 2018, respectively.

NOI is a non-GAAP financial measure that is defined as net income or loss (computed in accordance with GAAP) before: (i) general and administrative expenses; (ii) transaction expenses; (iii) depreciation and amortization expense; (iv) impairment; (v) interest expense and net change in fair value of derivative financial instruments; (vi) gain or loss on sales of real estate; (vii) gain or loss on extinguishment of debt; (viii) income or loss from unconsolidated joint venture; and (ix) other income or expense.  HTA believes that NOI provides an accurate measure of the operating performance of its operating assets because NOI excludes certain items that are not associated with the management of its properties.  Additionally, HTA believes that NOI is a widely accepted measure of comparative operating performance of real estate investment trusts ("REITs").  However, HTA's use of the term NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of HTA's financial performance.  NOI should be reviewed in connection with other GAAP measurements.

Cash NOI is a non-GAAP financial measure which excludes from NOI: (i) straight-line rent adjustments; (ii) amortization of below and above market leases/leasehold interests and other GAAP adjustments; and (iii) notes receivable interest income.  Contractual base rent, contractual rent increases, contractual rent concessions and changes in occupancy or lease rates upon commencement and expiration of leases are a primary driver of HTA's revenue performance.  HTA believes that Cash NOI, which removes the impact of straight-line rent adjustments, provides another measurement of the operating performance of its operating assets.  Additionally, HTA believes that Cash NOI is a widely accepted measure of comparative operating performance of REITs.  However, HTA's use of the term Cash NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of its financial performance.  Cash NOI should be reviewed in connection with other GAAP measurements.

To facilitate the comparison of Cash NOI between periods, HTA calculates comparable amounts for a subset of its owned and operational properties referred to as "Same-Property".  Same-Property Cash NOI excludes (i) properties which have not been owned and operated by HTA during the entire span of all periods presented and disposed properties, (ii) HTA's share of unconsolidated joint ventures, (iii) development, redevelopment and land parcels, (iv) properties intended for disposition in the near term which have (a) been approved by the Board of Directors, (b) are actively marketed for sale, and (c) an offer has been received at prices HTA would transact and the sales process is ongoing, and (v) certain non-routine items.  Same-Property Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of its financial performance.  Same-Property Cash NOI should be reviewed in connection with other GAAP measurements.

HEALTHCARE TRUST OF AMERICA, INC.

FFO, NORMALIZED FFO AND NORMALIZED FAD

(In thousands, except per share data)

(Unaudited)

 
 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

2019

 

2018

 

2019

 

2018

Net income attributable to common stockholders

$

16,259

   

$

15,346

   

$

29,699

   

$

25,148

 

Depreciation and amortization expense related to investments in real estate

67,846

   

68,585

   

136,772

   

138,441

 

Loss on sale of real estate, net

   

   

37

   

 

Impairment

   

   

   

4,606

 

Proportionate share of joint venture depreciation and amortization

450

   

463

   

922

   

814

 

FFO attributable to common stockholders

$

84,555

   

$

84,394

   

$

167,430

   

$

169,009

 

Transaction expenses

296

   

252

   

336

   

443

 

Noncontrolling income from OP units included in diluted shares

301

   

297

   

534

   

478

 

Other normalizing items, net

   

144

   

   

144

 

Normalized FFO attributable to common stockholders

$

85,152

   

$

85,087

   

$

168,300

   

$

170,074

 

Non-cash compensation expense

2,102

   

2,224

   

5,491

   

5,703

 

Straight-line rent adjustments, net

(2,464)

   

(2,377)

   

(5,722)

   

(5,543)

 

Amortization of (below) and above market leases/leasehold interests and corporate assets, net

325

   

559

   

657

   

1,310

 

Deferred revenue - tenant improvement related and other income

(2)

   

(43)

   

(3)

   

(109)

 

Amortization of deferred financing costs and debt discount/premium, net

1,407

   

1,291

   

2,812

   

2,580

 

Recurring capital expenditures, tenant improvements and leasing commissions

(13,402)

   

(14,511)

   

(25,264)

   

(25,861)

 

Normalized FAD attributable to common stockholders

$

73,118

   

$

72,230

   

$

146,271

   

$

148,154

 
               

Net income attributable to common stockholders per diluted share

$

0.08

   

$

0.07

   

$

0.14

   

$

0.12

 

FFO adjustments per diluted share, net

0.32

   

0.33

   

0.66

   

0.69

 

FFO attributable to common stockholders per diluted share

$

0.40

   

$

0.40

   

$

0.80

   

$

0.81

 

Normalized FFO adjustments per diluted share, net

0.01

   

0.01

   

0.01

   

0.00

 

Normalized FFO attributable to common stockholders per diluted share

$

0.41

   

$

0.41

   

$

0.81

   

$

0.81

 
               

Weighted average diluted common shares outstanding

209,005

   

209,259

   

209,002

   

209,218

 

HTA computes FFO in accordance with the current standards established by NAREIT.  NAREIT defines FFO as net income or loss attributable to common stockholders (computed in accordance with GAAP), excluding gains or losses from sales of real estate property and impairment write-downs of depreciable assets, plus depreciation and amortization related to investments in real estate, and after adjustments for unconsolidated partnerships and joint ventures.  Because FFO excludes depreciation and amortization unique to real estate, among other items, it provides a perspective not immediately apparent from net income or loss attributable to common stockholders.

HTA computes Normalized FFO, which excludes from FFO: (i) transaction expenses; (ii) gain or loss on extinguishment of debt; (iii) noncontrolling income or loss from OP Units included in diluted shares; and (iv) other normalizing items, which include items that are unusual and infrequent in nature.  HTA's methodology for calculating Normalized FFO may be different from the methods utilized by other REITs and, accordingly, may not be comparable to other REITs.

HTA also computes Normalized FAD, which excludes from Normalized FFO: (i) non-cash compensation expense; (ii) straight-line rent adjustments; (iii) amortization of below and above market leases/leasehold interests and corporate assets; (iv) deferred revenue - tenant improvement related and other income; (v) amortization of deferred financing costs and debt premium/discount; and (vi) recurring capital expenditures, tenant improvements and leasing commissions.  HTA believes this non-GAAP financial measure provides a meaningful supplemental measure of its operating performance.  Normalized FAD should not be considered as an alternative to net income or loss attributable to common stockholders (computed in accordance with GAAP) as an indicator of its financial performance, nor is it indicative of cash available to fund cash needs.  Normalized FAD should be reviewed in connection with other GAAP measurements.

HTA presents these non-GAAP financial measures because it considers them important supplemental measures of its operating performance and believes they are frequently used by securities analysts, investors and other interested parties in the evaluation of REITs.  Historical cost accounting assumes that the value of real estate assets diminishes ratably over time.  Since real estate values have historically risen or fallen based on market conditions, many industry investors have considered the presentation of operating results for real estate companies that use historical cost accounting to be insufficient by themselves.  These non-GAAP financial measures should not be considered as alternatives to net income or loss attributable to common stockholders (computed in accordance with GAAP) as indicators of its financial performance.  FFO and Normalized FFO is not indicative of cash available to fund cash needs.  These non-GAAP financial measures should be reviewed in connection with other GAAP measurements.

HEALTHCARE TRUST OF AMERICA, INC.

NET DEBT TO ADJUSTED EBITDAre

(Unaudited and in thousands)

 
 

Three Months Ended

 

June 30, 2019

Net income

$

16,598

 

Interest expense

24,006

 

Depreciation and amortization expense

68,429

 

Proportionate share of joint venture depreciation and amortization

450

 

EBITDAre

$

109,483

 

Transaction expenses

296

 

Non-cash compensation expense

2,102

 

Pro forma impact of acquisitions

673

 

Adjusted EBITDAre

$

112,554

 
   

Adjusted EBITDAre, annualized

$

450,216

 
   

As of June 30, 2019:

 

Debt

$

2,567,008

 

Less: cash and cash equivalents

23,194

 

Net Debt

$

2,543,814

 
   

Net Debt to Adjusted EBITDAre

5.7

x

As defined by NAREIT, EBITDAre is computed as net income or loss (computed in accordance with GAAP) plus: (i) interest expense; (ii) income tax expense (not applicable to HTA); (iii) depreciation and amortization; (iv) impairment; (v) gain or loss on the sale of real estate; and (vi) and the proportionate share of joint venture depreciation and amortization.

Adjusted EBITDAre is presented on an assumed annualized basis.  HTA defines Adjusted EBITDAre as EBITDAre (computed in accordance with NAREIT as defined above) plus: (i) transaction expenses; (ii) gain or loss on extinguishment of debt; (iii) non-cash compensation expense; (iv) pro forma impact of its acquisitions/dispositions; and (v) other normalizing items.  HTA considers Adjusted EBITDAre an important measure because it provides additional information to allow management, investors, and its current and potential creditors to evaluate and compare its core operating results and its ability to service debt.

Cision View original content:http://www.prnewswire.com/news-releases/healthcare-trust-of-america-inc-reports-second-quarter-2019-earnings-300889604.html

SOURCE Healthcare Trust of America, Inc.

 
 
Company Codes: NYSE:HTA
 
MORE ON THIS TOPIC